Karmanos Cancer Institute awarded $3M NIH grant to study triple-negative breast cance

[News]

Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit have received a nearly $3 million, five-year research project (RO1) grant from the National Institutes of Health to study a potentially ground-breaking immunotherapy treatment for women with one of the deadliest forms of breast cancer – triple-negative breast cancer. The research is exclusive to the Karmanos Cancer Institute.

More... (http://www.news-medical.net/news/20101019/Karmanos-Cancer-Institute-awarded-243M-NIH-grant-to-study-triple-negative-breast-cancer.aspx)